Drug Profile
CB 10277
Alternative Names: DM-COOKLatest Information Update: 26 Nov 2007
Price :
$50
*
At a glance
- Originator The Institute of Cancer Research
- Class Antineoplastics; Benzoic acids
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malignant melanoma
Most Recent Events
- 20 Sep 2000 No-Development-Reported for Malignant melanoma in United Kingdom (Infusion)
- 30 Nov 1994 Phase-II clinical trials for Malignant melanoma in United Kingdom (Infusion)